Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.

Standard

Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. / Brüggemann, Norbert; Hagenah, Johann; Reetz, Kathrin; Schmidt, Alexander; Kasten, Meike; Buchmann, Inga; Eckerle, Susanne; Bähre, Manfred; Münchau, Alexander; Djarmati, Ana; van der Vegt, Joyce; Siebner, Hartwig; Binkofski, Ferdinand; Ramirez, Alfredo; Behrens, Maria I; Klein, Christine.

In: ARCH NEUROL-CHICAGO, Vol. 67, No. 11, 11, 2010, p. 1357-1363.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Brüggemann, N, Hagenah, J, Reetz, K, Schmidt, A, Kasten, M, Buchmann, I, Eckerle, S, Bähre, M, Münchau, A, Djarmati, A, van der Vegt, J, Siebner, H, Binkofski, F, Ramirez, A, Behrens, MI & Klein, C 2010, 'Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.', ARCH NEUROL-CHICAGO, vol. 67, no. 11, 11, pp. 1357-1363. <http://www.ncbi.nlm.nih.gov/pubmed/21060012?dopt=Citation>

APA

Brüggemann, N., Hagenah, J., Reetz, K., Schmidt, A., Kasten, M., Buchmann, I., Eckerle, S., Bähre, M., Münchau, A., Djarmati, A., van der Vegt, J., Siebner, H., Binkofski, F., Ramirez, A., Behrens, M. I., & Klein, C. (2010). Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. ARCH NEUROL-CHICAGO, 67(11), 1357-1363. [11]. http://www.ncbi.nlm.nih.gov/pubmed/21060012?dopt=Citation

Vancouver

Brüggemann N, Hagenah J, Reetz K, Schmidt A, Kasten M, Buchmann I et al. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. ARCH NEUROL-CHICAGO. 2010;67(11):1357-1363. 11.

Bibtex

@article{20072c13190d48abb9260a4364c7b287,
title = "Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.",
abstract = "To determine clinical features and to identify changes in brain structure and function in compound heterozygous and heterozygous ATP13A2 mutation carriers.",
keywords = "Humans, Male, Aged, Female, Middle Aged, Prospective Studies, Genetic Predisposition to Disease, Magnetic Resonance Imaging, Mutation, Phenotype, Brain pathology, Pedigree, Heterozygote, Brain Mapping, Color Perception physiology, Discrimination (Psychology) physiology, Nerve Degeneration genetics, Olfactory Perception physiology, Parkinsonian Disorders genetics, Proton-Translocating ATPases genetics, Humans, Male, Aged, Female, Middle Aged, Prospective Studies, Genetic Predisposition to Disease, Magnetic Resonance Imaging, Mutation, Phenotype, Brain pathology, Pedigree, Heterozygote, Brain Mapping, Color Perception physiology, Discrimination (Psychology) physiology, Nerve Degeneration genetics, Olfactory Perception physiology, Parkinsonian Disorders genetics, Proton-Translocating ATPases genetics",
author = "Norbert Br{\"u}ggemann and Johann Hagenah and Kathrin Reetz and Alexander Schmidt and Meike Kasten and Inga Buchmann and Susanne Eckerle and Manfred B{\"a}hre and Alexander M{\"u}nchau and Ana Djarmati and {van der Vegt}, Joyce and Hartwig Siebner and Ferdinand Binkofski and Alfredo Ramirez and Behrens, {Maria I} and Christine Klein",
year = "2010",
language = "Deutsch",
volume = "67",
pages = "1357--1363",
number = "11",

}

RIS

TY - JOUR

T1 - Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.

AU - Brüggemann, Norbert

AU - Hagenah, Johann

AU - Reetz, Kathrin

AU - Schmidt, Alexander

AU - Kasten, Meike

AU - Buchmann, Inga

AU - Eckerle, Susanne

AU - Bähre, Manfred

AU - Münchau, Alexander

AU - Djarmati, Ana

AU - van der Vegt, Joyce

AU - Siebner, Hartwig

AU - Binkofski, Ferdinand

AU - Ramirez, Alfredo

AU - Behrens, Maria I

AU - Klein, Christine

PY - 2010

Y1 - 2010

N2 - To determine clinical features and to identify changes in brain structure and function in compound heterozygous and heterozygous ATP13A2 mutation carriers.

AB - To determine clinical features and to identify changes in brain structure and function in compound heterozygous and heterozygous ATP13A2 mutation carriers.

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Genetic Predisposition to Disease

KW - Magnetic Resonance Imaging

KW - Mutation

KW - Phenotype

KW - Brain pathology

KW - Pedigree

KW - Heterozygote

KW - Brain Mapping

KW - Color Perception physiology

KW - Discrimination (Psychology) physiology

KW - Nerve Degeneration genetics

KW - Olfactory Perception physiology

KW - Parkinsonian Disorders genetics

KW - Proton-Translocating ATPases genetics

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Genetic Predisposition to Disease

KW - Magnetic Resonance Imaging

KW - Mutation

KW - Phenotype

KW - Brain pathology

KW - Pedigree

KW - Heterozygote

KW - Brain Mapping

KW - Color Perception physiology

KW - Discrimination (Psychology) physiology

KW - Nerve Degeneration genetics

KW - Olfactory Perception physiology

KW - Parkinsonian Disorders genetics

KW - Proton-Translocating ATPases genetics

M3 - SCORING: Zeitschriftenaufsatz

VL - 67

SP - 1357

EP - 1363

IS - 11

M1 - 11

ER -